Literature DB >> 27411791

[Unclear liver lesions in a 19-year-old woman with acute myeloid leukemia].

B Braun1, A P Karl2, C Dierkes2, M Schenk3, J Braess3.   

Abstract

A 19-year old woman with acute myeloid leukemia presented with newly observed liver lesions during ongoing consolidation therapy. Due to unexplained cholestasis during induction, biliary duct drainage was performed. Microbiologic and histologic examinations revealed the presence of atypical mycobacteria, namely Mycobacterium abscessus. With an appropriate antiinfective regime which was continuously administered using a portable pump in the outpatient setting, further mycobacterial spread during simultaneous chemotherapy-associated neutropenia was prevented. Despite multiple bacterial resistance mechanisms, proper treatment of leukemia with curative intention could be ensured.

Entities:  

Keywords:  Atypical mycobacteria; Drug resistance, multiple; Leukemia, myeloid, acute; Liver lesions; Mycobacterium abscessus

Mesh：

Substances：

Year:  2016        PMID： 27411791     DOI： 10.1007/s00108-016-0104-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


  10 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.

Authors:  Florian P Maurer; Vera L Bruderer; Claudia Ritter; Claudio Castelberg; Guido V Bloemberg; Erik C Böttger
Journal:  Antimicrob Agents Chemother       Date:  2014-04-21       Impact factor: 5.191

3.  Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others.

Authors:  Jason E Stout; R Andres Floto
Journal:  Am J Respir Crit Care Med       Date:  2012-11-01       Impact factor: 21.405

Review 4.  Mycobacterium abscessus: a new antibiotic nightmare.

Authors:  Rachid Nessar; Emmanuelle Cambau; Jean Marc Reyrat; Alan Murray; Brigitte Gicquel
Journal:  J Antimicrob Chemother       Date:  2012-01-30       Impact factor: 5.790

5.  Rapidly growing mycobacteria infection in patients with cancer.

Authors:  Gil Redelman-Sidi; Kent A Sepkowitz
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

6.  Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

Authors:  Bas J Wouters; Bob Löwenberg; Claudia A J Erpelinck-Verschueren; Wim L J van Putten; Peter J M Valk; Ruud Delwel
Journal:  Blood       Date:  2009-01-26       Impact factor: 22.113

7.  Catheter-related Mycobacterium abscessus bacteremia manifested with skin nodules, pneumonia, and mediastinal lymphadenopathy.

Authors:  Shou-Hsin Su; Yen-Hsu Chen; Tung-Yuan Tsai; Su-Chiao Huang; Chun-Yu Lin; Tun-Chieh Chen; Po-Liang Lu
Journal:  Kaohsiung J Med Sci       Date:  2012-10-07       Impact factor: 2.744

8.  Catheter-related bloodstream infections caused by rapidly growing nontuberculous mycobacteria: a case series including rare species.

Authors:  Claudia Hawkins; Chao Qi; John Warren; Valentina Stosor
Journal:  Diagn Microbiol Infect Dis       Date:  2008-02-21       Impact factor: 2.803

Review 9.  Mycobacterium abscessus: a new player in the mycobacterial field.

Authors:  Halima Medjahed; Jean-Louis Gaillard; Jean-Marc Reyrat
Journal:  Trends Microbiol       Date:  2010-01-08       Impact factor: 17.079

10.  Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.

Authors:  Annika Dufour; Friederike Schneider; Klaus H Metzeler; Eva Hoster; Stephanie Schneider; Evelyn Zellmeier; Tobias Benthaus; Maria-Cristina Sauerland; Wolfgang E Berdel; Thomas Büchner; Bernhard Wörmann; Jan Braess; Wolfgang Hiddemann; Stefan K Bohlander; Karsten Spiekermann
Journal:  J Clin Oncol       Date:  2009-12-28       Impact factor: 44.544
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.